FHA
CLVS

Flagship Harbor Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Flagship Harbor Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed – – 1913
2020
Q3 		$0 Hold
100
– – ﹤0.01% 2222
2020
Q2 		$0 Sell
100
-140
-58% -$1.06K ﹤0.01% 2196
2020
Q1 		$2K Hold
240
– – ﹤0.01% 1697
2019
Q4 		$3K Buy
240
+110
+85% +$800 ﹤0.01% 1676
2019
Q3 		$0 Hold
130
– – ﹤0.01% 2010
2019
Q2 		$1K Hold
130
– – ﹤0.01% 1826
2019
Q1 		$3K Buy
130
+30
+30% +$752 ﹤0.01% 1634
2018
Q4 		$1K Hold
100
– – ﹤0.01% 1790
2018
Q3 		$3K Hold
100
– – ﹤0.01% 1857
2018
Q2 		$4K Buy
+100
New +$4.86K ﹤0.01% 1731

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Flagship Harbor Advisors's CLVS Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 100 shares.

Flagship Harbor Advisors first reported a position in CLVS in Q2 2018 and held it in 10 quarters. The position peaked at $4K in Q2 2018. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 100 Clovis Oncology, Inc. shares in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Clovis Oncology, Inc. in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Clovis Oncology, Inc. position peaked at $4K in Q2 2018.
  • 159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.